Insulet Corp (PODD)
174.43
+1.01
(+0.58%)
USD |
NASDAQ |
May 03, 16:00
174.46
+0.03
(+0.02%)
After-Hours: 20:00
Insulet Cash from Financing (TTM): -13.60M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -13.60M |
September 30, 2023 | -30.30M |
June 30, 2023 | -27.30M |
March 31, 2023 | -32.10M |
December 31, 2022 | -40.30M |
September 30, 2022 | -27.30M |
June 30, 2022 | 18.80M |
March 31, 2022 | 48.80M |
December 31, 2021 | 40.70M |
September 30, 2021 | 172.30M |
June 30, 2021 | 140.60M |
March 31, 2021 | 596.10M |
December 31, 2020 | 605.50M |
September 30, 2020 | 273.00M |
June 30, 2020 | 520.70M |
March 31, 2020 | 53.00M |
December 31, 2019 | 73.50M |
September 30, 2019 | 274.28M |
June 30, 2019 | 17.17M |
March 31, 2019 | 1.67M |
December 31, 2018 | -8.70M |
September 30, 2018 | 290.77M |
June 30, 2018 | 292.13M |
March 31, 2018 | 292.70M |
December 31, 2017 | 304.50M |
Date | Value |
---|---|
September 30, 2017 | 5.659M |
June 30, 2017 | 185.35M |
March 31, 2017 | 181.68M |
December 31, 2016 | 176.57M |
September 30, 2016 | 176.90M |
June 30, 2016 | -6.211M |
March 31, 2016 | -4.804M |
December 31, 2015 | -0.371M |
September 30, 2015 | 3.139M |
June 30, 2015 | -26.79M |
March 31, 2015 | 7.22M |
December 31, 2014 | 4.032M |
September 30, 2014 | 3.315M |
June 30, 2014 | 35.29M |
March 31, 2014 | 2.413M |
December 31, 2013 | 96.39M |
September 30, 2013 | 95.76M |
June 30, 2013 | 96.11M |
March 31, 2013 | 96.78M |
December 31, 2012 | 3.388M |
September 30, 2012 | 1.977M |
June 30, 2012 | 1.722M |
March 31, 2012 | 52.78M |
December 31, 2011 | 55.10M |
September 30, 2011 | 74.99M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-40.30M
Minimum
Dec 2022
605.50M
Maximum
Dec 2020
140.19M
Average
48.80M
Median
Mar 2022
Cash from Financing (TTM) Benchmarks
Abbott Laboratories | -7.091B |
Stryker Corp | -1.531B |
Tandem Diabetes Care Inc | 4.113M |
Becton Dickinson & Co | -1.949B |
ResMed Inc | -914.60M |